Assessment of the efficacy of the absorbable modified starch hemostasis powder to control bleeding in debridement of acute burn wounds, A randomized controlled clinical trial. Burns of multiple regions, unspecified degree
Conditions
Interventions
Intervention 1: How to use the powder (produced by Bani Zeet Bespar Hilda under the management of Dr. Hamid Mohammadi) in the operating room: After issuing the relevant license from the Ethics Committ
Sponsors
Vice President for Research and Technology, Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
6 Years to No maximum
Inclusion criteria
Inclusion criteria: Acute burn patients of Amiralmoemenin Hospital who undergo surgery. Accepting and signing the informed consent of the legal guardian of the patients to allow the use of the powder produced under controlled conditions for the patient
Exclusion criteria
Exclusion criteria: Patients with underlying liver problems Patients with behavioral problems Patients with mental problems Patients with superficial second-degree burns
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bleeding control time. Timepoint: The time to reach blood coagulation is checked in three minutes after spraying the powder. If necessary, it is repeated after three minutes if the powder has been removed and the wound bleeds again. Method of measurement: Inspection. | — |
Secondary
| Measure | Time frame |
|---|---|
| Bleeding control time. Timepoint: The time to reach blood coagulation is checked in three minutes after spraying the powder. Method of measurement: timer.;Blood coagulation quality. Timepoint: The time to reach blood coagulation is checked in three minutes after spraying the powder. Method of measurement: Inspection. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAbdolkhalegh Keshavarzi
Shiraz University of Medical Sciences
Outcome results
None listed